Skip to main content

Table 7 Application of the proposed method for the content uniformity test of Contrahistadin® and Kast® tablets

From: Development of a green synchronous spectrofluorimetric technique for simultaneous determination of Montelukast sodium and Bilastine in pharmaceutical formulations

Tablet number

% Recovery

MTK (Kast® 10 mg)

BIL (Contrahistadin® 20 mg)

1

98.30

100.93

2

96.66

99.89

3

97.18

97.14

4

105.62

97.45

5

99.96

99.82

6

102.95

98.92

7

97.38

99.39

8

100.29

97.08

9

99.36

102.59

10

98.37

104.01

Mean XÌ…

99.61

99.72

S

2.80

2.30

AVa

7.75

6.26

L1a

15

15

  1. aL1: maximum allowed acceptance value, AV: acceptance value